Nebivolol Eg (Nebivolol)

Nebivolol is a selective β1‑adrenergic blocker used in cardiovascular disease management.

• Hypertension: lowers systolic and diastolic blood pressure in patients with essential hypertension.
• Heart failure (reduced ejection fraction): improves ventricular function and reduces hospitalization risk.
• Left ventricular systolic dysfunction: supports cardiac output and symptom control in chronic heart failure.

• Nebivolol selectively antagonizes β1‑adrenergic receptors, reducing heart rate and myocardial contractility. In addition, it stimulates endothelial nitric oxide release, causing vasodilation and further decreasing peripheral vascular resistance, which together lower arterial pressure and improve cardiac efficiency.

Nebivolol may cause adverse reactions that vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate pain in the head region.
• Dizziness: sensation of light‑headedness, especially on standing.
• Fatigue: reduced energy or feeling unusually tired.
• Bradycardia: slower than normal heart rate.
• Nausea: upset stomach with urge to vomit.
• Peripheral edema: swelling of ankles or lower legs.

Serious or Rare Side Effects

• Severe bradycardia: markedly low heart rate requiring medical attention.
• Atrioventricular block: impaired electrical conduction in the heart.
• Bronchospasm: narrowing of airways, particularly in asthmatic patients.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Hepatic enzyme elevation: abnormal liver function tests.
• Hypotension: dangerously low blood pressure causing faintness.

Nebivolol should be used with careful clinical monitoring.

• Blood pressure monitoring: check regularly to avoid excessive hypotension.
• Cardiac function assessment: evaluate heart rate and ECG, especially in patients with conduction disorders.
• Asthma or COPD caution: use only if benefits outweigh risk of bronchospasm.
• Concomitant beta‑blocker use: avoid duplicate therapy to prevent excessive β‑blockade.
• Renal impairment adjustment: consider dose modification in severe renal dysfunction.
• Store at room temperature: keep in the original container, protect from moisture and light.

Nebivolol can interact with several drug classes, requiring clinical awareness.

Major Interactions (Avoid)

• Other beta‑blockers: additive cardiac depression.
• Calcium channel blockers (verapamil, diltiazem): may cause severe bradycardia or AV block.
• Anti‑arrhythmic agents (e.g., amiodarone): increase risk of conduction abnormalities.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: enhanced hypotensive effect.
• Diuretics: potential for excessive blood pressure drop.
• NSAIDs: may blunt antihypertensive response.
• Antidepressants (e.g., SSRIs): possible pharmacokinetic changes.